These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice. Lacoste B; Tong XK; Lahjouji K; Couture R; Hamel E J Neuroinflammation; 2013 May; 10():57. PubMed ID: 23642031 [TBL] [Abstract][Full Text] [Related]
6. Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-beta 1-40 peptide in mice. Amaral FA; Lemos MT; Dong KE; Bittencourt MF; Caetano AL; Pesquero JB; Viel TA; Buck HS Neuropeptides; 2010 Apr; 44(2):93-7. PubMed ID: 19926131 [TBL] [Abstract][Full Text] [Related]
7. Primary Role for Kinin B Nicoletti NF; Sénécal J; da Silva VD; Roxo MR; Ferreira NP; de Morais RLT; Pesquero JB; Campos MM; Couture R; Morrone FB Mol Neurobiol; 2017 Dec; 54(10):7869-7882. PubMed ID: 27848207 [TBL] [Abstract][Full Text] [Related]
8. Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo. Viel TA; Buck HS Curr Alzheimer Res; 2011 Feb; 8(1):59-66. PubMed ID: 21143155 [TBL] [Abstract][Full Text] [Related]
9. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes. Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198 [TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility to amyloid-β-induced neurotoxicity in mice lacking the low-density lipoprotein receptor. de Oliveira J; Moreira EL; dos Santos DB; Piermartiri TC; Dutra RC; Pinton S; Tasca CI; Farina M; Prediger RD; de Bem AF J Alzheimers Dis; 2014; 41(1):43-60. PubMed ID: 24577472 [TBL] [Abstract][Full Text] [Related]
12. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884 [TBL] [Abstract][Full Text] [Related]
13. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
14. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer's Disease Pathological Characteristics in a Transgenic Mouse Model. Nunes MA; Toricelli M; Schöwe NM; Malerba HN; Dong-Creste KE; Farah DMAT; De Angelis K; Irigoyen MC; Gobeil F; Araujo Viel T; Buck HS Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33019732 [TBL] [Abstract][Full Text] [Related]
16. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995 [TBL] [Abstract][Full Text] [Related]
17. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
18. Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. Albert-Weissenberger C; Stetter C; Meuth SG; Göbel K; Bader M; Sirén AL; Kleinschnitz C J Cereb Blood Flow Metab; 2012 Sep; 32(9):1747-56. PubMed ID: 22569191 [TBL] [Abstract][Full Text] [Related]
19. Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors. Rodrigues ES; Silva RF; Martin RP; Oliveira SM; Nakaie CR; Sabatini RA; Merino VF; Pesquero JB; Bader M; Shimuta SI Peptides; 2013 Apr; 42():1-7. PubMed ID: 23306173 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease. Gagnon M; Savard M; Tran TMH; Vincent L; Moquin A; Tremblay P; Roucou X; Dory Y; Gobeil F Molecules; 2023 Jul; 28(13):. PubMed ID: 37446867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]